19961113
 French drug maker reaps profits with offbeat strategy   By Moore, Stephen D, The Wall Street Journal,  Nov 14, 1996  The strategy of tapping erstwhile rivals for research funds in return for licenses to sell some of its hottest drugs--thus sharing both the risks and rewards--has helped French pharmaceutical company Sanofi SA become a major player since it entered the drug business in 1973. The company's ambitions could soar higher following Nov 13, 1996's announcement that one of its drugs in clinical trials could become a blockbuster.   
